MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

Discover what a backdoor Roth IRA is and how it works, how to set one up, the rules you must follow, and when a backdoor IRA might not be the right choice for you.